Abstract Requirements
Abstracts must conform with the following guidelines.

Click Here to download and print abstract policies. 

Important Dates: 
Abstract Submission Site Opens: May 13, 2021
Abstract Deadline: Monday, June 14, 2021
Notification Sent: Week of July 12, 2021


  • There is a non-refundable abstract fee of $35 USD per abstract, due at the time of abstract submission. Payments must be made via credit card on the submission site; checks are not accepted.
  • This abstract fee does not register you for the meeting. All accepted abstracts must be registered separately in order to be included in the Annual Meeting. The abstract submission fee is a non-refundable processing fee, and not based on approval of your abstract submission or attendance at the Annual Meeting. No refunds will be processed, even if an abstract is withdrawn.

What’s Included?

  • The abstract fee covers submission of your abstract and administrative fees for processing and reviewing abstracts. Accepted abstracts will be published in the ‘Human Immunology’ journal supplement, as well as in the virtual platform, at no additional charge.

Why is there an abstract fee?

  • There is a large cost associated with collecting, processing, and reviewing all abstracts. This nominal fee helps to ensure all abstracts will be processed and peer-reviewed at the highest standards.

Abstract Preparation:

  • Abstracts must be submitted and presented in English.

Abstract Titles

  • All capital letters
  • No abbreviations
  • No period at the end
  • No author or institutions included in the title

Author/Institution Information

  • Authors will be printed in the order entered.
  • Include the following when entering institution information: institution, city, state/province, and country.

Abstract Presentation

  • Abstracts will be presented in-person (in Orlando) on Monday, September 27, 2021 from 7:00pm - 9:00pm EDT and on Tuesday, September 28, 2021 from 6:00pm - 8:00pm EDT in the Windsong Ballroom at the Hyatt Regency Grand Cypress.
  • Abstracts will be also available in a virtual platform and mobile application. The requested format will be 3 slides in a PowerPoint presentation with a 3-minute voice-over narration. This will be submitted as an .mp4 video format. More details will follow in notices sent the week of July 12, 2021.

Abstract Formatting

  • Character Limit: Abstracts are limited to 2,500 characters.  This includes text plus any graphic/table.
  • Tables/graphics deduct 250 characters no matter how many characters the table itself contains. The submission site supports the following graphic formats: gif, png, tiff, tif, jpeg and jpg.
  • Abbreviations: A maximum of five (5) unique abbreviations are allowed within the body of the abstract.
  • Format: Abstracts of original work and case studies should be structured into the following four (4) content sections:
    • Aim
    • Methods
    • Results
    • Conclusions


  • Selected abstracts will be published in a supplement of Human Immunology which will serve as the official abstract book for the meeting.
  • Abstracts will also be posted in the virtual platform on-demand service up to one year after the ASHI 47th Annual Meeting.

Co-Author Approval

  • Ensure that all co-authors approve of the abstract submission, publication, and potential presentation.

Contact Author

  • The presenting author will serve as the contact author and will be responsible for completing the disclosure information for all co-authors.  

Abstract Withdrawal

  • Abstracts cannot be withdrawn after Monday, June 14, 2021 11:59 PM, Eastern Time.  
  • To withdraw an abstract prior to Monday, June 14, 2021 11:59 PM, Eastern Time, please log in to ScholarOne with your credentials and follow the instructions on how to withdraw. 

Abstract Review

  • Abstracts are blindly reviewed and graded by experts in the field.  They will be reviewed based on their clinical significance and scientific innovation.  Abstracts failing this criteria will not be accepted.


  • The complete program and all selected abstracts will be posted on the ASHI website prior to the meeting.  Please note: Authors must agree to publish their submission online and in the journal in order to be considered for oral or poster presentation.  

Previous Presentation of Abstracts

  • Abstracts are NOT considered for presentation if they were either published as an article or previously presented at a national or international meeting prior to the date of their presentation.  

Informed Consent

  • Any studies involving human subjects must conform to the principles of the Declaration of Helsinki of the World Medical Association (Clinical Research 1966: 14:103) and must meet all the requirements governing informed consent of the country in which the study was performed.  Any transplant procedures performed must meet with the prevailing ethical standards.  

Use of Animals

  • All studies involving the use of animals must conform to the 1991 revision of "Guiding Principles in the Care and Use of Animals" (American Physiological Association).


  • Awards will be issued to the first author of each abstract.  The first author is considered the lead researcher and takes primary responsibility for the abstract.  
    • International Scholar: $500.00 awarded to the highest-ranked international abstract. 
    • ASHI Scholar: $225.00 awarded to the top three abstracts.
    • Case Study Awards: The highest-ranking case studies - one for stem cell and one for solid organ - will be presented at the respective workshops and will receive a $200.00 award.  Awardees will be announced during the final symposium session.  
    • Posters may be considered for awards in four categories: Most Innovative, Most Clinically Relevant, People's Choice and President's Choice.  To be eligible, you must indicate during the abstract process whether you would like to be considered for one of these awards.  A maximum of four awards will be granted.  Winning posters will be announced at the Awards Symposium and will receive a ribbon and award of $100.00 each.

Changes to Abstracts After Submission

  • You can edit the abstract in the submission site up until the submission deadline of Monday, June 14, 2021 11:59 PM, Eastern Time.


  • When you have completed your online abstract form, click Finalize Abstract, but ONLY when you are sure that your abstract is complete and in final form.


  • Abstract notifications will be sent the Week of July 12, 2021.  Abstracts will be accepted based on the clinical significance and scientific innovation.  Abstracts falling outside of these parameters will not be accepted.